Communications Medicine
Title Abbreviation
Commun Med (Lond)
Electronic ISSN
2730-664X
Therapeutic Area
Anti-Aging, Biology, Biotechnology, Cardiology, Diagnostic Imaging, General Medicine, Internal Medicine, Neurology, Oncology, Public Health, Research
Readership
Biomedical Researchers, Cardiologists, Clinicians, Epidemiologists, Health Scientists, Internists, Neurologists, Oncologists, Physicians, Physicians - Medicine, Physicists, Public Health Professionals, Researchers, Technologists
Scope
Communications Medicine is a selective open access journal from Nature Portfolio publishing high-quality research, reviews and commentary across all clinical, translational, and public health research fields. The journal aims to foster collaboration across these different communities to facilitate discovery that will promote health and improve patients’ lives. Primary research papers published by the journal represent significant advances in preventing, diagnosing, or treating human disease of relevance to a specialized field. We provide a forum to discuss issues of importance to researchers across all the communities in our readership, regardless of sub-discipline or medical specialty.
The scope of Communications Medicine covers studies in: all clinical specialties, such as oncology, cardiology or neurology; emerging fields, such as precision medicine, microbiome, or anti-aging therapies; any area of translational research; regional or global public health.
We are also interested in submissions at the intersection of medicine with other scientific disciplines, such as computational science and physics, where the central advance of the study is of interest to the medical community, for example digital medicine and medical devices or imaging.
Primary research published in Communications Medicine includes the following study types: observational and interventional clinical studies (all phases of trials and case studies/series); observational and interventional epidemiological studies (prospective and retrospective); systematic reviews and meta-analysis; new methods, technologies or resources of significant translational or clinical relevance; studies in pre-clinical models of significant relevance to disease diagnosis/therapy.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Nature Publishing Group - UK
Electronic Circulation
Submission to Acceptance
Frequency
Author Submission Guidelines